Current Issue January 2012, Vol. 30, No. 1

In This Issue

Prostate-specific antigen (PSA) should drive doing prostate biopsies
January 2012 (Vol. 30 | No. 1 | Pages 1-2)
Stacy Loeb, William J. Catalona
- Full Text
- PDF (104 KB)
The multi-disciplinary management of high-risk prostate cancer
January 2012 (Vol. 30 | No. 1 | Pages 3-15)
Jonathan C. Picard, Ali-Reza Golshayan, David T. Marshall, Krisha J. Opfermann, Thomas E. Keane
GREB1 tissue expression is associated with organ-confined prostate cancer
January 2012 (Vol. 30 | No. 1 | Pages 16-20)
Alberto A. Antunes, Kátia R. Leite, Sabrina T. Reis, Juliana M. Sousa-Canavez, Luiz H. Camara-Lopes, Marcos F. Dall'Oglio, Miguel Srougi

Prostate cancer risk prediction in a urology clinic in Mexico
06 February 2012
Yuanyuan Liang, Jamie C. Messer, Christopher Louden, Miguel A. Jimenez-Rios, Ian M. Thompson, Hector R. Camarena-Reynoso
Abstract: Objectives: To evaluate factors affecting the risk of prostate cancer (CaP) and high-grade disease (HGCaP, Gleason score ≥ 7) in a Mexican referral population, with comparison to the Prostat...
Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance
02 February 2012
Guillaume Ploussard, Alexandre de la Taille, Stéphane Terry, Yves Allory, Idir Ouzaïd, Francis Vacherot, Claude-Clément Abbou, Laurent Salomon
Abstract: Objective: To evaluate the impact of detailed biopsy characteristics such as positive cores location or multifocality on the risk of initial reclassification in prostate cancer (CaP) patient...
Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma
02 February 2012
Julia Straub, Frank Strittmatter, Alexander Karl, Christian G. Stief, Stefan Tritschler
Abstract: Objectives: To determine accuracy of upper tract cytology and ureteroscopic biopsy according to the 2004 World Health Organization (WHO) classification in predicting the correct tumor grade ...
Summary of the 6th annual bladder cancer think tank: New directions in urologic research
02 February 2012
Robert S. Svatek, Jonathan E. Rosenberg, Matthew D. Galsky, Cheryl T. Lee, David M. Latini, Bernard H. Bochner, Alon Z. Weizer, Andrea B. Apolo, Srikala S. Sridhar, Ashish M. Kamat, Donna Hansel, Thomas W. Flaig, Norm D. Smith, Yair Lotan
Abstract: The 6th Annual Bladder Cancer Think Tank brought together a multidisciplinary group of clinicians, researchers, and representatives from the National Cancer Institute and Industry in an effo...
Fibroblast growth factor receptor-3 in urothelial tumorigenesis☆
30 January 2012
Gopa Iyer, Matthew I. Milowsky
Abstract: Fibroblast growth factor receptor-3 (FGFR3) is a receptor tyrosine kinase implicated in the tumorigenesis of multiple malignancies, including bladder and other urothelial cancers, multiple m...

View More Articles in Press...

On the Cover

New Issue Alert

Free Trial Issue

Journal Ranking

2010 Impact Factor: 3.172

Ranks 15th of 69 journals in the Urology & Nephrology category.

© 2011 Journal Citation Reports®, Thomson Reuters

Journal Access

Full-text articles are available from 1995 to the present. (The numbering gap between Volumes 7 and 21 results from a title merger.) Access to abstracts is complimentary. Access to full text is limited to Society of Urologic Oncology members as well as personal subscribers.

Activate Online Access

Publishing Information

Urologic Oncology: Seminars and Original Investigations is published by Elsevier for the Society of Urologic Oncology (SUO).

Access this journal onSciVerse ScienceDirect

Seminar Section

Impact of poverty and race/ethnicity on treatment and management of urologic cancers

KATHERINE S. VIRGO, PH.D., M.B.A., GUEST EDITOR

Impact of poverty and race/ethnicity on treatment and management of urologic cancers Free

About SUO

The Society of Urologic Oncology (SUO) was created in 1984 to enable qualified members primarily interested in the care of patients with malignant genitourinary diseases to meet for the purpose of discussion, development, and implementation of ideas to improve care. The Society and its bylaws conform to the guidelines and bylaws of the American Urological Association (AUA).

About Urologic Oncology: Seminars and Original Investigations

Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. This new journal combines the original research from Urologic Oncology: Seminars and Original Investigations with the comprehensive single topic overviews from Seminars in Urologic Oncology. The combined publication delivers timely clinical research and up-to-date comprehensive reviews of critical scientific relevance. Each issue comprises original articles and reviews including an in-depth Seminar examining a specific clinical dilemma. All articles are of significant interest to all clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.